التفاصيل البيبلوغرافية
| العنوان: |
Ibrutinib in the management of Waldenstrom macroglobulinemia. |
| المؤلفون: |
Yosef, Amir, Touloukian, Emily Z., Nambudiri, Vinod E. |
| المصدر: |
Journal of Oncology Pharmacy Practice; Mar2019, Vol. 25 Issue 2, p434-441, 8p, 1 Chart |
| مصطلحات موضوعية: |
ANTINEOPLASTIC agents, LYMPHOPROLIFERATIVE disorders, CELL proliferation, CELLULAR signal transduction, DRUG resistance, IMMUNOTHERAPY, GENETIC mutation, SURVIVAL, PHARMACODYNAMICS, PROTEIN-tyrosine kinase inhibitors, PREVENTION, THERAPEUTICS |
| مستخلص: |
Bruton tyrosine kinase plays a critical role in hastening cell proliferation. Bruton tyrosine kinase inhibitors are a class of immunotheraputic agents that disrupt this signaling pathway. Ibrutinib, a novel Bruton tyrosine kinase inhibitor approved by the Food and Drug Administration (FDA) for the treatment of Waldenstrom macroglobulinemia in patients who have failed treatment with other agents, has emerged as an important therapeutic agent in the management of Waldenstrom macroglobulinemia and other plasma cell dyscrasias. Ibrutinib has shown to increase progression free survival and improve overall mortality. We present a review of ibrutinib, beginning with an overview of the Bruton tyrosine kinase pathway and clinically relevant gene mutations impacting treatment and prognosis for patients with Waldenstrom macroglobulinemia, followed by evidence supporting therapeutic indications for ibrutinib, and detailing its safety and efficacy evidence, current clinical guidelines, adverse effects and their management, and finally challenges of drug resistance. We also present findings on newly developed Bruton tyrosine kinase inhibitors in the therapeutic pipeline to provide readers insight into this rapidly evolving corner of oncology pharmacy practice. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Oncology Pharmacy Practice is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
